SteelPeak Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.1M Buy
+22,594
New +$10.1M 0.39% 66
2024
Q4
Sell
-20,163
Closed -$9.38M 540
2024
Q3
$9.38M Buy
20,163
+19,604
+3,507% +$9.12M 0.41% 56
2024
Q2
$262K Sell
559
-20,936
-97% -$9.81M 0.01% 382
2024
Q1
$8.99M Buy
21,495
+1,436
+7% +$600K 0.45% 52
2023
Q4
$8.16M Buy
20,059
+19,456
+3,227% +$7.92M 0.47% 58
2023
Q3
$210K Sell
603
-545
-47% -$190K 0.01% 363
2023
Q2
$404K Sell
1,148
-111
-9% -$39.1K 0.02% 264
2023
Q1
$397K Sell
1,259
-12,963
-91% -$4.08M 0.03% 260
2022
Q4
$4.11M Buy
14,222
+13,422
+1,678% +$3.88M 0.3% 72
2022
Q3
$232K Buy
+800
New +$232K 0.02% 352
2021
Q3
Sell
-3,734
Closed -$753K 446
2021
Q2
$753K Buy
3,734
+2,516
+207% +$507K 0.05% 202
2021
Q1
$262K Sell
1,218
-8,310
-87% -$1.79M 0.02% 310
2020
Q4
$2.25M Sell
9,528
-6,849
-42% -$1.62M 0.2% 94
2020
Q3
$4.46M Buy
16,377
+1,126
+7% +$306K 0.48% 56
2020
Q2
$4.43M Buy
+15,251
New +$4.43M 0.56% 52